The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Compass Pathways. However, as the price target is maintained at $21, it suggests that the analyst does not foresee significant short-term price movement. Therefore, the short-term impact on the stock price is neutral.